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Abstract
Zn supplementation has shown inconsistent effects on respiratory morbidity in young children in developing countries. Few studies have
focused on upper respiratory tract infection (URTI), a frequent cause of morbidity in this group, and potential benefit from Zn supplemen-
tation or factors that influence its efficacy. We investigated the effects of Zn supplementation on URTI before and after vitamin A sup-
plementation. This randomised double-blinded controlled Zn supplementation study was conducted on 826 children aged 2–5 years.
Placebo or Zn (10 mg/d) was given in syrup daily for 4 months, with 200 000 IU vitamin A (60 mg retinol) given to all children at
2 months. Health workers visited children every 3 d for compliance and morbidity information. We found that 84 % of children experienced
URTI during the study. Zn supplementation reduced the percentage of days with URTI (12 % reduction; P¼0·09), with greater impact
following vitamin A supplementation (20 % reduction; P¼0·01). Vitamin A supplementation was associated with a decreased number
but an increased duration of URTI episodes. We conclude that Zn combined with vitamin A supplementation significantly reduced the
percentage of days with URTI in a population of preschool Indonesian children with marginal nutritional status. The results suggest
that vitamin A status modifies the efficacy of Zn supplementation on URTI.
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Amongst the micronutrients, deficiencies of Zn and vitamin A
are thought to have the largest impact on disease burden in
preschool children, and together have been estimated to
account for 9 % of the global burden in this age group(1).
A recent meta-analysis of randomised controlled trials of Zn
supplementation showed that supplementation reduced sig-
nificantly the frequency and severity of childhood respiratory
illnesses, but the authors also noted significant heterogeneity
in trial outcomes(2). Vitamin A supplementation has resulted
in significant reductions in mortality in several community-
based trials in apparently healthy children(3), prompting
many governments to introduce routine supplementation
programmes. However, the benefits of vitamin A supplemen-
tation have not been consistent across trials, particularly
for respiratory morbidity, where evidence suggests that sup-
plementation may increase the risk of adverse outcomes in
some conditions(3).
Some aspects of a functional interaction between Zn and
vitamin A are well described. For example, Zn is essential
for the synthesis of retinol-binding protein, is needed for the
conversion of retinol to retinal for dark adaptation and for
the lymphatic absorption of retinol(4,5). Zn supplementation
has also been shown to improve vitamin A biochemical indi-
ces in children with low or marginal vitamin A status(6,7).
However, few supplementation trials have examined the prac-
tical importance of the interaction for childhood respiratory
morbidity. In a trial amongst children aged 12–35 months in
the urban slums of Dhaka, Bangladesh, Rahman et al.(8)
showed a significant increase in acute lower respiratory infec-
tion with Zn alone, but an interaction and net positive effect
from combined vitamin A and Zn supplementation. In con-
trast, Long et al.(9) in children aged 6–15 months from a
peri-urban area of Mexico City showed that vitamin A sup-
plementation was associated with an increase in cough with
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fever, Zn supplementation had no independent effect on res-
piratory morbidity, and there was no significant interaction.
While the weight of evidence is toward Zn and vitamin A sup-
plementation having generally beneficial effects on childhood
morbidity, these studies showed potentially adverse effects on
respiratory morbidity from supplementing with Zn or vitamin
A alone, and the need to understand better the conditions
under which Zn alone or combined with vitamin A sup-
plementation will be beneficial.
Vitamin A deficiency has been a significant public health
nutrition problem in Indonesia and Zn deficiency also appears
to be widespread(10,11). Further, upper respiratory tract infec-
tion (URTI) is a frequent cause of childhood morbidity,
which could have an impact on growth(12) and risk of other
diseases such as otitis media and sinusitis or exacerbate
asthma attacks(13). Therefore, we carried out a placebo-con-
trolled trial of Zn supplementation in the presence and
absence of vitamin A supplementation to examine the effects
on URTI morbidity in preschool children in an urban area of
Indonesia.
Subjects and methods
Mothers of all children aged 2–5 years attending thirty-six
posyandu (health centres) in Semarang, Indonesia were
invited to join the study. The age group was selected due to
their relatively high risk of both malnutrition – including vita-
min A deficiency – and URTI, and the feasibility of selecting a
community-based sample of this age through the posyandu.
Apparently healthy children aged 2–5 years were included.
Moderately and severely malnourished children, defined by
a weight-for-height # 2 2 SD of the WHO/National Center
for Health Statistics reference(14) were excluded, as malnu-
trition may modify a treatment effect from supplementation.
Of the 1047 children who were present at recruitment, 826
apparently healthy children were included in the study.
The present study was randomised and double-blinded for
Zn or placebo supplementation. Children were recruited
during June 2003 and given a Zn supplement or placebo
daily for 4 months. At 2 months after recruitment (i.e.
August), children received a single-dose vitamin A supplement
(200 000 IU; 60 mg retinol) as part of the routine bi-annual
national vitamin A supplementation programme. This schedul-
ing meant that the vitamin A status of the children was likely
to be at its lowest in June and July – before the vitamin A sup-
plementation – while the opposite would be true in Septem-
ber and October. Thus the two treatment groups (Zn or
placebo) could be compared during two time periods,
before and after vitamin A supplementation.
The ‘before vitamin A’ supplementation period was defined
as starting at 1 d after recruitment, which was 4 months after
the previous routine vitamin A supplementation, and ending
on the day of vitamin A supplementation for each child.
The ‘after vitamin A’ supplementation period started 1 d after
vitamin A supplementation and ended on the last day of
supplement consumption and observation, that is, 2 months
after routine vitamin A supplementation.
The effect of Zn supplementation was measured by
comparing the URTI morbidity in the Zn (415 children) and
placebo (411 children) groups. The effect of vitamin A
supplementation was measured by comparing URTI morbidity
in the same 826 children during the two different time periods.
Thus, four comparison groups were defined: placebo (no Zn
and no vitamin A) (A); Zn only (B); vitamin A only (C); and
Zn plus vitamin A (D). Fig. 1 shows the study design, partici-
pant selection process and reasons for loss to follow-up.
Micronutrient supplementation
In each posyandu, one of the physicians (not investigators)
used random numbers to allocate each child to receive daily
either Zn (10 mg elemental Zn) or a placebo syrup for the 4
months. Supplements were prepared and labelled with alpha-
betic codes by the Pharmacy Department of Diponegoro Uni-
versity. There was no difference between the syrups in taste or
appearance. Trained health workers were recruited from the
thirty-six posyandu and made home visits to each subject
every third day. During these visits they supervised consump-
tion of syrup, recorded compliance data and observed the
amount of syrup left in the bottles. They supplied new bottles
of syrup to mothers each fortnight, rotating strawberry and
lemon flavours to maximise compliance. Both health workers
and mothers were blinded to the syrup content. Non-compli-
ance was defined as syrup consumption on less than 75 % of
the total supplement days. Of the children, four stopped
taking the supplement during the first 2 months of the study
as they moved out of the areas and did not take part for the
remainder of the study, and twenty-four stopped during the
last 2 months.
The present study was conducted according to the guide-
lines laid down in the Declaration of Helsinki and all pro-
cedures involving human subjects were approved by the
Medical Research Ethics Committee of The University of
Queensland and Ethical Committee of Medical Research of
Medical Faculty, Diponegoro University. Written informed
consent was obtained from the mothers of all subjects.
Sample size
The underlying incidence rate for URTI was assumed to be
8·11 (SD 2·43) per child year(15). A sample of 764 children,
382 in each group, was required to detect a 20 % difference
in URTI incidence rate between comparison groups with a
power of 80 %, a 95 % significance level, and 20 % loss to
follow-up.
Morbidity data collection
The health workers also collected morbidity data during their
visits every third day by observing the child’s health status on
that day and interviewing mothers regarding their child’s
health status for the two previous days. If the child was
found to have a cough, respiratory rate was measured. If
they had at least one URTI symptoms (see below), axillary
temperature was measured using a digital thermometer.
M. I. Kartasurya et al.2252
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The results of the observation and interview were recorded
on structured questionnaires and reported to supervising
physicians fortnightly. The latter diagnosed URTI based on
symptoms reported, and randomly checked children’s health
status and visited the subjects if necessary.
An URTI episode was defined as the presence of at least two
of the following clinical symptoms experienced for at least 1 d:
runny nose (ongoing discharge from the nose), cough, sore
throat and raised body temperature, or one of the symptoms
for at least 2 d, without the signs of difficult or rapid breathing.
A total of three aspects of URTI morbidity, namely the number
of episodes, percentage of days with URTI and duration per
episode, were used as dependent variables in the present
study. A period of three illness-free days between the episodes
was required for a new episode to be defined. This definition
of URTI episode is adapted from definitions used in previous
randomised controlled Zn supplementation studies(16–19)
modified to specifically measure URTI (instead of respiratory
infections more generally, or irritation problem) in pre-
school-age children. The percentage of days with URTI was
defined as the number of days with URTI divided by the
number of observation days, expressed as a percentage. The
duration of URTI episodes was defined as the number of
days with URTI for each episode.
Other measurements
Child and family characteristics and socio-economic data were
collected at baseline by interview using structured question-
naires. Anthropometric assessment was conducted at baseline
by trained undergraduate nutrition students using standard
protocols(20) – weight measured on a Seca portable digital
scale to the nearest 100 g, and height measured standing
using a measuring board to the nearest 0·1 cm. Z scores for
anthropometric indicators were calculated based on WHO/
National Center for Health Statistics reference distributions
using Nutrisoft software (Nutrition Research and Development
Centre, Health Research and Development Institute of Indone-
sian Ministry of Health).
Non-fasting venous blood was drawn from the children at
baseline, between 09.00 and 12.00 hours. Serum retinol was
determined using HPLC at the Institute of Nutrition, Mahidol
1047 children present at
recruitment 
221 children excluded: 
207 sick at recruitment,
12 not met inclusion criteria,
2 not living in the area of
study
826 children were randomised 
411 children
received placebo
A group
(no Zn no vitamin A):
409 children 
Baseline
measurement
2 stopped taking
placebo
415 children
received Zn
B group
(Zn only):
413 children
2 stopped taking
Zn
2 months measurement
Vitamin A given 
10 stopped taking
placebo
14 stopped taking
Zn
C group
(vitamin A only):
399 children
4 months
measurement
D group
(Zn plus vitamin A):
399 children
Fig. 1. Study design and included subjects.
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University, Thailand. Intra-assay CV was 3·5 % and inter-assay
CV 6·1 %. Vitamin A deficiency was defined as serum retinol
,0·7mmol/l and low vitamin A status defined as serum retinol
,1·05mmol/l(21). C-reactive protein was measured using an
ELISA kit (K9710s; Immundiagnostik) with optical density
values read at 450 nm. Intra- and inter-assay CV were 8·5
and 10·0 %, respectively. Hair samples (1–2 cm; about
50 mg) were cut from close to the scalp in the occipital area
using stainless steel scissors that had been washed in deio-
nised water. The samples were stored in labelled polyethylene
zip-locked bags at room temperature. Analysis was conducted
at Queensland Health Scientific Services, Australia. Hair
samples were washed three times using the hexane–ethanol
method(22), acid digested using concentrated nitric acid and
assayed using a Varian inductively coupled plasma atomic
emission spectrometer (ICP-AES). The intra- and inter-assay
CV were 4·7 and 8·6 %, respectively. Hair Zn is known to
vary by day-length or season and different cut-offs are rec-
ommended for spring and summer (,1·07mmol/g) v. winter
(,1·68mmol/g) seasons(23). Prevalence using both criteria is
reported.
Data analysis
SAS software (version 9.1; SAS Institute, Inc.) was used for
analysing the number of episodes and percentage of days
with URTI, and SPSS (version 13.0; SPSS, Inc.) for URTI dur-
ation. The analysis was initially conducted on an intention-
to-treat basis, with the code of Zn or placebo syrup broken
only after the initial analyses were completed. Compliance
and subgroup effects were considered in subsequent analyses.
Potential confounders considered were socio-demographic
status, sex, compliance (days of supplement consumption),
initial anthropometric status, Zn and vitamin A status at base-
line and posyandu code. The latter was included to control for
cluster effects. Although in a randomised controlled study
these factors could be regarded as similar across the groups,
their significance was assessed by inclusion in the models.
The final models included only the significant variables.
The effects of supplementation on the number of episodes
of URTI and percentage of days ill were measured in relative
risks. The GENMOD procedure of SAS 9.1 was used with a
negative binomial distribution. In the models for URTI epi-
sodes the number of observation days was included as a cov-
ariate to control for observation period. The effect of
supplementation on URTI duration per episode was assessed
using the repeated measures option in the general linear
model (GLM) procedure of SPSS 13.0. URTI duration was ana-
lysed in log form, as this variable was not normally distributed
in the original value but normalised after log transformation.
The results presented in the tables have been back-transformed
to the original values. Log URTI duration per episode before
and log URTI duration per episode after vitamin A supplemen-
tation were set as the dependent variables, time (before and
after vitamin A supplementation period) as two levels of
within-subject factor, treatment as the between-subjects
factor and potential confounding variables as the covariates.
Only important covariates as judged by P value less than
0·05 were included in the models.
The effect of the interaction between Zn and vitamin A sup-
plementation was assessed by comparing morbidity rates in
the Zn plus vitamin A and the placebo groups (DþA) with
the rates in the Zn and the vitamin A groups (B þ C).
P values of less than 0·05 were regarded as significant and
P values between 0·05 and 0·1 as marginally significant.
Results
Characteristics of the 826 study children at commencement of
the study are presented in Table 1. There were no differences
in age, anthropometric status and socio-economic conditions
between the subjects who received Zn v. placebo. Baseline
vitamin A and Zn status were also similar across groups, as
reflected in the mean serum retinol and hair Zn levels. The
overall prevalence of vitamin A deficiency was very low
(2·3 %); however, a significant proportion (32·4 %) was at
risk of low vitamin A status. The proportion with hair Zn
levels ,1·07mmol/g (spring and summer cut-off) was low at
5·3 %, with 20·3 % below ,1·68mmol/g (winter cut-off).
Compliance with supplement consumption was high; 96 %
consumed the supplement on .75 % of days, with amounts
consumed slightly higher in the last 2 months of the study. The
mean number of days with syrup consumption in each group
was: A, 56·4 (SE 0·28); B, 56·1 (SE 0·32); C, 61·9 (SE 0·44); D,
60·9 (SE 0·47), respectively. The median number of days with
syrup consumption in each group was: A, 58 (range 29–67);
B, 58 (range 21–73); C, 64 (range 0–80); D, 64 (range 0–79),
respectively.
Overall, 84 % of the study children had an episode of URTI
at some point during the study period, the number of episodes
ranging from zero to twelve per child, with a mean of 2·84
(SE 0·08) episodes. About 70 % of the subjects had fever
during these episodes. The percentage of days with URTI
during the study period was 13·4 (SE 0·5) %, and the mean dur-
ation per episode was 5·7 (SE 0·2) d. By contrast, the next most
common illness was diarrhoea, with 14 % of children affected,
and only two children were diagnosed with an episode of
lower respiratory tract infection (LRTI) during the 4 months.
Table 2 shows URTI morbidity by treatment group and
Table 3 shows the treatment effects. The main effect of Zn
across the 4 months of supplementation was a 12 % reduction
in the percentage of days with URTI (P¼0·09). The effect was
different between the before and after vitamin A supplemen-
tation periods, with a reduction of 20 % following the distri-
bution of vitamin A. Vitamin A alone had no effect on the
percentage of days with URTI (no difference in the placebo
before and after vitamin A supplementation); however, the
effect was very strong on children who received Zn sup-
plementation, with a reduction of 9 % in the percentage of
days with URTI associated with the ‘interaction effect’, and
an overall significant main effect for vitamin A.
The main effect of Zn was not significant for URTI episodes;
however, vitamin A supplementation was associated with
a significant (P¼0·00) reduction (23 %) in the number of
URTI episodes. The children who received both Zn and
M. I. Kartasurya et al.2254
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vitamin A had the lowest number of episodes, with a 6 %
reduction in the number of episodes associated with the ‘inter-
action effect’ compared with the combined effects of Zn and
vitamin A individually (P¼0·07).
For URTI duration per episode, Zn had no significant main
effect and there was no significant interaction between Zn and
vitamin A supplementation. The vitamin A main effect was a
significant increase in the duration of URTI by 0·6 d.
Figs. 2 and 3 present results of stratified analysis with effects
estimated for subgroups of sex, age and baseline nutritional
status. In the final model the number of observation days
was a significant covariate for the analysis of number of
URTI episodes but not other models; posyandu was retained
in the models to control for possible cluster effects. The vita-
min A main effect on URTI episodes was statistically signifi-
cant for all subgroups. The effect magnitude was the
greatest in the younger children (,3·5 years old) and girls,
though the CI for all subgroups overlapped. The Zn main
effect on episodes was variable and not significant for any
subgroup. The interaction tended to show a protective effect
across all subgroups, and was statistically significant only
amongst girls.
The results for the percentage of days with URTI suggest
greater heterogeneity. The vitamin A main effect was greater
in those ,3·5 years old than older children, with other sub-
group results showing a general pattern of modest protection
across subgroups. The Zn main effect was variable, and sig-
nificantly protective amongst girls, those underweight and
older children. The interaction effect was more consistent,
suggesting a moderate additional protection by combining
the treatments, with the most marked difference between
boys and girls that suggests no effect amongst boys.
Discussion
The subjects were from a generally healthy but relatively poor
suburban area of Semarang, in the province of Central Java.
Assessment of Zn status is hampered by the lack of a single,
specific and sensitive index, but hair Zn is frequently used
as an indicator of chronic Zn status(23). Serum retinol is most
useful as an indicator of vitamin A status when liver stores
are depleted(24). Despite these limitations, the results, together
with relatively low anthropometric measures, suggest a poor
nutritional history, including marginal micronutrient status
Table 2. Levels of upper respiratory tract infections (URTI) morbidity in a trial of zinc supplementation with and without concurrent vitamin A sup-
plementation in Indonesian preschool children
(Mean values with their standard errors)
Placebo (group A) Zn (group B) Vitamin A (group C)
Zn þ vitamin A
(group D)
n Mean SE n Mean SE n Mean SE n Mean SE
Percentage of days with URTI 410 14·1 0·8 415 13·8 0·8 410 14·2 0·8 415 11·6 0·8
Number of URTI episodes per child 411 1·52 0·1 415 1·53 0·1 411 1·38 0·1 415 1·23 0·1
Mean duration of URTI episode (d) 229 4·5 0·2 217 4·5 0·2 229 4·9 0·2 217 4·7 0·2
Table 1. Subject characteristics at the start of the study and compliance with zinc and placebo supplementation by treatment group (total n 826)
(Number of subjects, mean values with their standard errors, or percentages)
Subject characteristics
Placebo group Zn group
Significance of the
difference: P *n Mean SE n Mean SE
Male:female ratio 1·01 1·12 0·49
Age (years) 411 3·48 0·04 415 3·56 0·04 0·18
Anthropometric status
Weight-for-age Z score 410 21·48 0·04 413 21·55 0·04 0·28
Height-for-age Z score 410 21·70 0·05 413 21·76 0·05 0·37
Weight-for-height Z score 410 20·53 0·05 414 20·59 0·04 0·39
Micronutrient status
Serum retinol (mmol/l) 392 1·17 0·01 383 1·19 0·01 0·49
Hair Zn (mmol/g) 382 2·55 0·10 367 2·52 0·07 0·78
Socio-economic variables (%)
Father’s illiteracy rate 7 1·7 4 1·0 0·36
Mother’s illiteracy rate 27 6·6 33 8·0 0·74
House owned 301 73·2 299 72·2 0·76
House entirely made of brick 261 63·5 266 64·4 0·83
Low-income family† 298 72·5 286 68·9 0·29
Income per capita/month (thousand rupiahs) 411 154 114 415 162 113 0·32
Compliance with treatment (%)
, 75 % Days of syrup consumption 15 3·7 21 5·0 0·61
75–100 % Days of syrup consumption 396 96·4 394 94·9
* One-way ANOVA for continuous variables; x2 tests for categorical variables.
† Poverty line level used: 175 000 rupiahs/month (Indonesian Central Bureau of Statistics, 2006(33)).
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for vitamin A and Zn. In terms of factors that might influence
estimation of treatment effects, there were no important differ-
ences in characteristics between the treatment groups, compli-
ance was very high, with 96 % of the children consuming the
supplement on more than 75 % of days and similar compliance
across groups.
The children in the present study had a relatively high inci-
dence of URTI, with 84 % of the children affected, and a mean
2·84 episodes during 4 months of follow-up or 8·52 episodes
per child-year. This was similar to the incidence of 8·11/
child-year reported elsewhere in Indonesia(15).
The Zn supplementation, which was conducted as a
double-blind randomised controlled trial over the full 4-
month study showed a reduction of 12 % in the percentage
of days with URTI. Furthermore, the effect was modified fol-
lowing vitamin A supplementation, with a greater reduction
(20 %) seen after vitamin A supplementation. The results
show a potentially important interaction between the vitamin
A and Zn supplementation, with those receiving both sup-
plements having 9 % fewer days with URTI and 6 % fewer
URTI episodes than expected from the independent effects
of vitamin A and Zn.
Because we could not randomly allocate the timing for vita-
min A supplementation it is possible that the interaction effect
was caused by other differences beside the treatments that
might alter URTI risk between the before and after vitamin A
supplementation periods. However, available evidence
suggests that this is not the case. First, both periods (June–
July and August–September) were in the dry season period
in Indonesia (Indonesia has only two seasons: dry from
April to October and wet from October to April). Data from
the local primary health care centre showed no important
differences between the numbers of visits for respiratory infec-
tion between June–July and August–September in 2002, 2003
and 2004 (Puskesmas Bangetayu Report, unpublished results).
Data from the City Health Office (unpublished results) showed
that the number of LRTI reported was also not different during
that time period. Second, the percentage of days with URTI in
the placebo group before and after vitamin A supplementation
was essentially identical, suggesting a relatively constant level
of risk over the 4 months.
There is growing evidence of an interaction between Zn
and vitamin A that is consistent with vitamin A status modify-
ing the effect of Zn supplementation on URTI morbidity. The
combined effects in the present study are estimated to be a
reduction of 34 % in episodes and 30 % in the percentage of
days with URTI. This may slightly overestimate the interaction
because children starting Zn supplementation at baseline
(analysis group B) would be expected to have poorer Zn
status than at the start of the second period following vitamin
A supplementation (group D), when they will already have
had 2 months of Zn supplement and would be expected to
be Zn replete.
As well as a marked effect on episodes and percentage of
days with URTI, the combined treatment appears to have
changed the nature of the morbidity. While the overall effect
on the percentage of days ill with URTI was a 9 % reduction
(across both treatment groups), there was a 23 % reduction
in the number of episodes and a 0·6 d increase in the average
duration of each episode. For the reasons above, it appears
unlikely that this effect can be explained by time difference.
The present results differ from other studies in several ways.
In terms of the Zn effect, a recent meta-analysis of Zn sup-
plementation trials showed a greater effect of Zn supplemen-
tation on episodes with LRTI or pneumonia than we observed
(20 % reduction), but not days with respiratory illness (non-
significant 5 % reduction)(25). The authors noted significant
heterogeneity across studies. An important difference between
the present study and most of the others is the type of morbid-
ity, with most previous trials focusing on acute LRTI or broad
definitions that would probably encompass both URTI and
LRTI. To the extent that the differences in morbidity defi-
nitions distinguish between URTI and LRTI, the divergence
in findings may be due to differences in the pathogens gener-
ally associated with upper v. lower respiratory infections,
often viral v. bacterial, respectively(26), and a differential
effect across these pathogens of immune changes induced
by vitamin A and by Zn.
Reviews of vitamin A supplementation trials and recently
reported studies have not shown a general effect of vitamin
A on respiratory infections in young children(3,15,27,28). Fur-
thermore, most studies showing benefit suggest that it is in
Table 3. Treatment effects in a trial of zinc supplementation with and without concurrent vitamin A supplementation in Indonesian preschool children
(Relative risks (RR) and 95 % confidence intervals)
Zn main effect:
(D þ B)/(A þ C)
Vitamin A main effect:
(C þ D)/(A þ B)
Zn effect after vitamin
A supplementation: (D/C)
Interaction effect:
(D þ A)/(B þ C)
RR 95 % CI P RR 95 % CI P RR 95 % CI P RR 95 % CI P
Percentage of days
with URTI*
0·88 0·75, 1·02 0·093 0·91 0·84, 0·98 0·014 0·80 0·67, 0·95 0·014 0·91 0·84, 0·98 0·016
Number of URTI episodes
per child†
0·95 0·86, 1·06 0·38 0·77 0·71, 0·84 0·000 0·90 0·78, 1·03 0·12 0·94 0·88, 1·01 0·073
Mean duration of URTI
episode (d)‡
Effect size 20·2 0·67 0·6 0·005 20·2 0·37 20·2 0·36
Group A, placebo; group B, Zn supplementation; group C, vitamin A supplementation; group D, Zn þ vitamin A supplementation; URTI, upper respiratory tract infection.
* Used GENMOD procedure in SAS, with negative binomial distribution; covariates in final model ¼ posyandu (health centre), observation days.
† Used GENMOD procedure in SAS, with negative binomial distribution; covariate in final model ¼ posyandu.
‡ Used repeated measures option in the general linear model (GLM) procedure of SPSS; covariate in final model ¼ posyandu.
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reducing the severity rather than incidence of infections(3).
The present study showed a reduction in the incidence of
URTI, but increase in URTI duration, which is one measure
of severity. However, Zn supplementation suggested a modifi-
cation of the deleterious effect in duration to lessen this effect.
Few trials have reported on the effects of combined vitamin
A and Zn supplementation on respiratory morbidity. Rahman
et al.(8) conducted a trial in children aged 12–35 months living
in urban slums of Dhaka, Bangladesh. They found no effect of
vitamin A alone on acute LRTI over 6 months of follow-up, a
significant increase in both episodes and days ill associated
with Zn supplementation alone, but a reduction in both
aspects of morbidity with combined vitamin A and Zn (signifi-
cant for days ill). They also reported that one-third of the
children had low vitamin A status, one-third had low serum
Zn at baseline, and vitamin A alone failed to correct vitamin
A deficiency, whereas combined supplementation with
vitamin A and Zn effectively corrected the deficiency(6).
Long et al.(9) also reported on the individual and combined
effects of vitamin A and Zn on respiratory infections in
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Fig. 2. Effect of supplementation on number of upper respiratory tract infection episodes by subgroups of weight-for-age, baseline vitamin A, age and sex. (a) Zn
main effect; (b) vitamin A main effect; (c) interaction effect. Values are relative risks, with 95 % confidence intervals represented by horizontal bars.
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children aged 6–15 months living in a peri-urban area of Mexico
City. They found a 23 % increase in episodes of ‘cough with
fever’ associated with vitamin A alone, no effect of Zn alone,
and the interaction to be non-significant. Importantly, the
authors noted that the prevalence of low serum vitamin A was
likely to be low (,5 %) with Zn deficiency likely to be lower
than the national prevalence (one-third of the children).
The heterogeneity across study findings suggests that the
vitamin A and Zn effects are modified by other factors. The
subgroup analysis in the present study provides some evi-
dence that the younger children (,3·5 years old) and girls
responded most overall, with no consistent patterns for any
influence of vitamin A status and underweight on treatment
effects. However, the present study was not primarily powered
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Fig. 3. Effect of supplementation on the percentage of days with upper respiratory tract infection by subgroups of weight-for-age, baseline vitamin A, age and sex.
(a) Zn main effect; (b) vitamin A main effect; (c) interaction effect. Values are relative risks, with 95 % confidence intervals represented by horizontal bars.
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for subgroup analyses and so these results are only indicative.
Furthermore, the supplementation period (2 months plus 2
months) was short relative to most other Zn supplementation
trials. Longer supplementation periods would have strength-
ened the capacity to examine both the overall and subgroup
effects (increased person-time exposure; longer periods Zn
replete). Importantly, the present study showed no evidence
for adverse outcomes for any subgroups.
A key finding in each of the studies testing the combined
effects of vitamin A and Zn on respiratory infection is that
the combined effect has been synergistic, with significant posi-
tive effects from the combination even when an individual
main effect has been negative. We noted earlier the evidence
for an interaction between vitamin A and Zn in storage, mobil-
isation and nutrient conversion(4,5). This could explain part of
the synergy, but it is probably also due to complementarity in
their effects on the immune response. Vitamin A is important
for maintaining the integrity of epithelial barriers. It also plays
an important role in other innate immune functions such as
phagocytic and oxidative burst activity of macrophage and
natural killer cell activities(3). Vitamin A also has an important
role in the development and differentiation of Th1 and
Th2 lymphocytes. This role in Th2 lymphocytes is essential
for extracellular pathogen defence(29). Zn has also been
known as an essential cofactor for thymulin, which modulates
cytokine release and proliferation, supporting a Th1 response,
maintaining skin and mucosal membrane integrity as
well as having a direct antiviral effect(29). The combination
of these effects could lead to only the more virulent pathogens
surviving to cause URTI, producing the effect of fewer
episodes but the longer duration or higher severity of
the URTI we observed. In contrast, studies of Zn supplemen-
tation on diarrhoeal morbidity show that it reduces the
severity of the illness(30–32). Trends in the present results
and the Bangladesh study provide support for this also occur-
ring for respiratory infections, but it needs to be further
examined.
Conclusion
Zn supplementation reduced the percentage of days with
URTI, a very common illness in this population of preschool
Indonesian children with marginal nutritional status, including
marginal Zn and vitamin A status. The greatest impact of Zn
supplementation was following routine vitamin A supplemen-
tation when the combined effects were estimated to be a
reduction of 34 % in episodes and 30 % in the percentage of
days with URTI.
The present study indicates an important public health
impact of combined Zn and vitamin A supplementation on
URTI in young children, especially in developing countries,
where the burden associated with URTI is high, as is the
associated morbidity due to otitis media, sinusitis and
asthma attacks. Moreover, the effect was sufficiently large to
protect the children against the aggravating effect of URTI
on growth rates, which are already low as a result of low
energy and micronutrient intakes in Indonesia.
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